Article
Dose of selective serotonin uptake inhibitors across pregnancy: Clinical implications
1 Jan 2000
Abstract excerpt
The use of antidepressants during pregnancy has undergone considerable scrutiny with respect to safety issues, though limited data with respect to dose management and symptom resolution is available. Previous reports on tricyclic antidepressants (TCAs) have demonstrated the need to adjust maternal dose later in pregnancy to maintain therapeutic serum concentrations. However, there is no data on the dosage of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
